## Abstract In a recent study, 5βyear survival rates for breast cancer patients in Boston (Massachusetts), Glamorgan (Wales), Slovenia (Yugoslavia) and Tokyo (Japan) were 57.3%, 49.5%, 41.9% and 74.9%, respectively. In this report, data are presented on the types of treatment used in the four areas
Some international differences in histology and survival in breast cancer
β Scribed by Alan S. Morrison; Maurice M. Black; C. Ronald Lowe; Brian Macmahon; Shu Yuasa
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- French
- Weight
- 513 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Survival rates for patients with breast cancer have been reported to be higher in Japan than in the United States. It has also been reported that histologic features associated with more favorable survival are more frequent in Tokyo than in the United States. In this report data are presented on the question of whether differences in breast cancer histology could account for the differences in survival rate between Tokyo and two western areasβBoston, USA, and Glamorgan, Wales. Intraductal carcinoma was found to be most frequent in Tokyo and least frequent in Boston, but survival differences between the two cities were found when nonβinvasive cases were excluded. Low (relatively malignant) nuclear grade was observed most often in Glamorgan; there was little difference in frequency of this characteristic between Boston and Tokyo. Since nuclearβgrade specific survival ratios were highest in Tokyo, this histologic feature also does not account for the better survival experience of Japanese patients. Tumors of medullary histologic type and those with high degrees of lymphoid infiltration were most frequent in Japan and least frequent in Boston. However, the relationships of histologic type and lymphoid infiltrate to survival were not consistent in the three areas, and the higher survival ratio of the Japanese patients could not be related to these characteristics.
π SIMILAR VOLUMES
## BACKGROUND. Survival after breast carcinoma diagnosis is significantly worse among African American women for reasons unknown. The purpose of this study was to update reports on the National Surveillance, Epidemiology, and End Results Program and to examine the effect of race on breast carcinom
3The data collection centers, and the principal investigator (PI), co-investigator (CI), and pathologist (P) at each participating center in alphabetical order by country, are as follows: